Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: Ferring Pharmaceuticals Ltd, Drayton Hall, Church Road, West Drayton, UB7 7PS
GHRH Ferring, Powder and solvent for solution for injection 50µg.
| Pharmaceutical Form |
|---|
|
Lyophilised powder for injection. Sterile solution for reconstitution of an injectable preparation. |
Active Ingredient: Somatorelin as acetate, 50 micrograms per ampoule.
| Active Ingredient | Description | |
|---|---|---|
| Somatorelin |
Somatorelin is normally synthesised in the hypothalamus and stimulates the secretion of growth hormone from the pituitary gland. Somatorelin physiologically increases plasma growth hormone levels. |
| List of Excipients |
|---|
|
Powder: No excipients Each diluent ampoule contains: Sodium chloride Ph.Eur 9mg |
GHRH Ferring is supplied in clear glass ampoules of high hydrolytic resistance (hydrolytic Class 1 according to Ph. Eur.).
The diluent is supplied in clear glass ampoules of high hydrolytic resistance (hydrolytic Class 1 according to Ph. Eur.).
Ferring Pharmaceuticals Ltd, Drayton Hall, Church Road, West Drayton, UB7 7PS
GHRH Ferring: PL 03194/0050
Diluent for GHRH Ferring: PL 03194/0051
24th October 2008
| Drug | Countries | |
|---|---|---|
| GHRH | Spain, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
